Zobrazeno 1 - 1
of 1
pro vyhledávání: '"levodopa/dopa-decarboxylase inhibitor"'
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 14, Pp 709-719 (2018)
Zhan-Miao Yi,1–3 Ting-Ting Qiu,1,4 Yuan Zhang,5 Na Liu,6 Suo-Di Zhai1,3 1Department of Pharmacy, Peking University Third Hospital, 2Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical Science, 3In
Externí odkaz:
https://doaj.org/article/2d3b69e18fd14e968c211717a2a7b186
